The central venous catheter market was valued at $2.57 billion in 2022 and is estimated to reach $4.73 billion by 2032, exhibiting a CAGR of 6.4% from 2023 to 2032.
Central venous catheters are defined as an indwelling device inserted into a large, central vein such as internal jugular, subclavian, or femoral. Central venous catheters are used for blood transfusion and infusion of chemotherapy drugs. These catheters are available with various numbers of lumens.
The growth of the central venous catheter market is driven by surge in incidence of cardiovascular diseases, increase in availability & affordability of healthcare treatment and rise in number of hospital admission. The increase in incidence of acute kidney injury and kidney failure drives the demand for central venous catheters. These catheters are used for hemodialysis. For instance, according to American Kidney Fund, in 2020, more than 562,000 Americans were on dialysis. Growth in a number of hemodialysis thus consequently drives the market growth.
Moreover, large medical technology firms have increasingly focused on acquiring companies that provide solutions for central venous catheters, which is expected to notably contribute toward the market growth. Prominent players in the global central venous catheter market have adopted various strategies such as product launches, acquisitions, and investments in R&D for advancement in central venous catheters to strengthen their position in the market and sustain the competitive environment. For instance, in January 2021, Shenzhen Prunus Technology Co., Ltd., acquired the critical care products division of Biosensors International Group, Ltd, officially entering the field of critical care consumables business. The acquired products of the subsidiary include central venous catheters, pressure transducers, pulmonary artery catheters, pacing catheters, thrombolysis catheters, urinary catheters, and other medical consumables.
Moreover, alarming increase in prevalence of kidney diseases, technological advancements in central venous catheter, and rise in the number of accidents and trauma are some of the key factors that drive the growth of the market. Furthermore, rise in geriatric population and changes in lifestyles notably contribute toward the growth in prevalence of diseases. However, concern related to catheter infections and product recalls by manufacturers is expected to hamper the market growth. Conversely, increased application of central venous catheter among the geriatric population and emergency health conditions is expected to provide lucrative opportunities for the growth of the market in the near future. In addition, extensive R&D activities in the field of central venous catheter along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market during the forecast period.
The central venous catheter market is segmented into product type, property, design, end user, and region. On the basis of product type, the market is bifurcated into tunneled catheters and non-tunneled catheters. On the basis of property, the market is bifurcated into antimicrobial catheters and non-antimicrobial catheters. On the basis of design, the market is classified into single lumen, double lumen and multiple lumens. On the basis of end user, it is classified into hospitals, cancer treatment centers, and others. On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major companies profiled in the report include AngioDynamics, Asahi Kasei Corporation., B. Braun, Becton Dickinson and Company, ICU Medical, Medtronic plc., Merit medical, Rex Medical, Teleflex Incorporated and Vygon Ltd.
Central venous catheters are defined as an indwelling device inserted into a large, central vein such as internal jugular, subclavian, or femoral. Central venous catheters are used for blood transfusion and infusion of chemotherapy drugs. These catheters are available with various numbers of lumens.
The growth of the central venous catheter market is driven by surge in incidence of cardiovascular diseases, increase in availability & affordability of healthcare treatment and rise in number of hospital admission. The increase in incidence of acute kidney injury and kidney failure drives the demand for central venous catheters. These catheters are used for hemodialysis. For instance, according to American Kidney Fund, in 2020, more than 562,000 Americans were on dialysis. Growth in a number of hemodialysis thus consequently drives the market growth.
Moreover, large medical technology firms have increasingly focused on acquiring companies that provide solutions for central venous catheters, which is expected to notably contribute toward the market growth. Prominent players in the global central venous catheter market have adopted various strategies such as product launches, acquisitions, and investments in R&D for advancement in central venous catheters to strengthen their position in the market and sustain the competitive environment. For instance, in January 2021, Shenzhen Prunus Technology Co., Ltd., acquired the critical care products division of Biosensors International Group, Ltd, officially entering the field of critical care consumables business. The acquired products of the subsidiary include central venous catheters, pressure transducers, pulmonary artery catheters, pacing catheters, thrombolysis catheters, urinary catheters, and other medical consumables.
Moreover, alarming increase in prevalence of kidney diseases, technological advancements in central venous catheter, and rise in the number of accidents and trauma are some of the key factors that drive the growth of the market. Furthermore, rise in geriatric population and changes in lifestyles notably contribute toward the growth in prevalence of diseases. However, concern related to catheter infections and product recalls by manufacturers is expected to hamper the market growth. Conversely, increased application of central venous catheter among the geriatric population and emergency health conditions is expected to provide lucrative opportunities for the growth of the market in the near future. In addition, extensive R&D activities in the field of central venous catheter along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market during the forecast period.
The central venous catheter market is segmented into product type, property, design, end user, and region. On the basis of product type, the market is bifurcated into tunneled catheters and non-tunneled catheters. On the basis of property, the market is bifurcated into antimicrobial catheters and non-antimicrobial catheters. On the basis of design, the market is classified into single lumen, double lumen and multiple lumens. On the basis of end user, it is classified into hospitals, cancer treatment centers, and others. On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major companies profiled in the report include AngioDynamics, Asahi Kasei Corporation., B. Braun, Becton Dickinson and Company, ICU Medical, Medtronic plc., Merit medical, Rex Medical, Teleflex Incorporated and Vygon Ltd.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the central venous catheter market analysis from 2022 to 2032 to identify the prevailing central venous catheter market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the central venous catheter market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global central venous catheter market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly update (only available with the purchase of an enterprise license)
- 5 additional company profiles of your choice, pre- or post-purchase, as a free update.
- Free updated version (once released) with the purchase of a 1-5 or enterprise user license.
- 16 analyst hours of support (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% free customization (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
- Free data pack (Excel version) with the purchase of a 1-5 or enterprise user license.
- Free report update, if the report is 6-12 months old or older.
- 24-hour priority response
- Free industry updates and white papers.
Key Market Segments
By Product type
- Tunneled Catheters
- Non-Tunneled Catheters
By Property
- Antimicrobial Catheters
- Non-Antimicrobial Catheters
By Design
- Single Lumen
- Double Lumen
- Multiple Lumen
By End-User
- Hospital
- Cancer treatment centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- B. Braun SE
- ICU Medical Inc.
- AngioDynamics, Inc.
- Medtronic plc
- Rex Medical, LLC.
- Vygon
- Asahi Kasei Corporation.
- Becton, Dickinson and Company
- Merit Medical Systems Inc.
- Teleflex Incorporated
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE
CHAPTER 5: CENTRAL VENOUS CATHETER MARKET, BY PROPERTY
CHAPTER 6: CENTRAL VENOUS CATHETER MARKET, BY DESIGN
CHAPTER 7: CENTRAL VENOUS CATHETER MARKET, BY END-USER
CHAPTER 8: CENTRAL VENOUS CATHETER MARKET, BY REGION
CHAPTER 9: COMPETITIVE LANDSCAPE
CHAPTER 10: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to this report, the central venous catheter market was valued at $2.6 billion in 2022, and is estimated to reach $4.7 billion by 2032, growing at a CAGR of 6.4% from 2023 to 2032.The Central venous catheter Market is likely to experience a significant growth rate of 6.4% from 2022-2032 owing to increasing market demand for antiemetic drugs
Central venous catheters are defined as an indwelling device inserted into a large, central vein such as internal jugular, subclavian, or femoral. Central venous catheters are used for blood transfusion and infusion of chemotherapy drugs. These catheters are available with various numbers of lumens such as single lumen, dual lumen and multi-lumens.
The key market trends driving the growth of the central venous catheter market include rise in demand for central venous catheter for treatment of accidental injury, improvements in healthcare infrastructure, and investments in R&D activities by key market players. In addition, rise in prevalence of chronic diseases such as cancer and diabetes contributes to the growth of the market. For instance, according to American Cancer Society (ACS) states that, a total of 1.9 million new cancer cases and 609,360 deaths from cancer are expected to occur in the U. S. in 2022, and cancer death rate for men and women combined has decreased to 32% from its peak in 1991 to 2019. The central venous catheters are used for the treatment of critically ill patients suffer with chronic diseases. Thus, high prevalence of chronic disease along with growing demand of central venous catheters is expected to drive the central venous catheter market during the forecast period.
In addition, a rise in awareness about the effectiveness of central venous catheter, surge in incidence of cardiovascular diseases, increase in availability & affordability of healthcare treatment and rise in number of hospital admission contributes to the growth of market. According to Centers for Disease Control and Prevention (CDC), Coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021. However, the concern related to infections associated with central venous catheter and the product recall by manufacturers are expected to restrict the market growth. Conversely, increased adoption of central venous catheter among the population is expected to provide lucrative opportunities for the growth of the market. On the contrary, rise in research and development activities by key market players and increase in healthcare expenditure has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities for the expansion of the central venous catheter market.
The market also offers growth opportunities to the key players in the market. The target population is in tremendous need of cost-effective services in regions like Europe and Asia-Pacific. Hence, challenges to cater the unmet needs of the target population provide growth opportunities. Online medical services have gained high traction in the last 4 years. As a result, engaged stakeholders in the industry have partnered with existing delivery services organizations.
The central venous catheter market is segmented into product type, property, design, end user, and region. On the basis of product type, the market is bifurcated into tunneled catheters and non-tunneled catheters. On the basis of property, the market is bifurcated into antimicrobial catheters and non-antimicrobial catheters. On the basis of design, the market is classified into single lumen, double lumen and multiple lumens. On the basis of end user, it is classified into hospitals, cancer treatment centers, and others. Region-wise, the market is studied across North America (the U. S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The key players profiled in the AngioDynamics, Asahi Kasei Corporation., B. Braun, Becton Dickinson and Company, ICU Medical, Medtronic plc., Merit medical, Rex Medical, Teleflex Incorporated and Vygon Ltd. The players in the market have been actively engaged in the adoption of various strategies such as acquisition, product launch, and partnership to remain competitive and gain an advantage over the competitors in the market
Key Market Insights (Updated)
On the basis of product type, the non-tunneled catheters segment was the major share contributor in 2022.
By property, the non-antimicrobial catheters segment dominated the market in 2022, and the speech therapy segment is expected to grow at the fastest CAGR during the forecast period.
On the basis of design, the double lumen segment is anticipated to grow with the highest CAGR throughout the forecast period.
By end user, the hospital segment held the highest position in terms of revenue in 2022, whereas homecare are expected to grow at the highest CAGR during the forecast period.
Region wise, North America garnered the largest revenue share in 2022, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- B. Braun SE
- ICU Medical Inc.
- AngioDynamics, Inc.
- Medtronic plc
- Rex Medical, LLC.
- Vygon
- Asahi Kasei Corporation.
- Becton, Dickinson and Company
- Merit Medical Systems Inc.
- Teleflex Incorporated
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
